Merkliste 
 1 Ergebnisse 
 
1

Phase 2 Study of Apatinib, A Novel VEGFR Inhibitor in Patie..:

Dou, S. ; Zhang, L. ; Li, R..
International Journal of Radiation Oncology*Biology*Physics.  100 (2018)  5 - p. 1378-1379 , 2018